Frank R.  Jimenez net worth and biography

Frank Jimenez Biography and Net Worth

Frank R. Jimenez is Vice President and General Counsel of GE HealthCare. Frank is responsible for all legal, government affairs, and compliance matters, including litigation, intellectual property and licensing, international trade compliance, labor & employment, data privacy, environmental, M&A, corporate governance, and business risk.

Previously, Frank served as Executive Vice President and General Counsel of Raytheon Technologies Corporation, a leader in technologies across the full spectrum of aviation, space and defense formed by the 2020 merger of Raytheon Company and United Technologies Corporation. In prior corporate positions, Frank served as General Counsel for Raytheon Company (defense), Bunge Limited (agribusiness and food), Xylem Inc. (fluid technology), and ITT Corporation (multi-industrial), where he managed the 2011 spin-offs of two public companies, Xylem and Exelis Inc. (defense technology).

In prior public service, Frank served as the 21st General Counsel of the Navy, one of seven Senate-confirmed Pentagon civilians of four-star equivalent rank overseeing the U.S. Navy and Marine Corps; Deputy General Counsel (Legal Counsel) of the U.S. Department of Defense; Principal Deputy General Counsel of the Navy; Chief of Staff at the U.S. Department of Housing and Urban Development; and Deputy Chief of Staff and Acting General Counsel for Florida Governor Jeb Bush. Previously, he was a litigation partner at Steel Hector & Davis (now Squire Patton Boggs) in Miami, FL, and clerked for Judge Pamela Ann Rymer of the U.S. Court of Appeals for the Ninth Circuit in Pasadena, CA.

Frank graduated from the University of Miami and the Yale Law School. He also holds an MBA from the University of Pennsylvania’s Wharton School and a master’s degree from the U.S. Naval War College. He serves on the boards of HII (Huntington Ingalls Industries), Equal Justice Works, and the Yale Law School Fund, and the advisory boards of the Columbia University Mailman School of Public Health, the Yale Law School Center for the Study of Corporate Law, the University of Miami Herbert Business School, and the National Security Institute of the Antonin Scalia Law School at George Mason University.

What is Frank R. Jimenez's net worth?

The estimated net worth of Frank R. Jimenez is at least $6.44 million as of May 1st, 2024. Mr. Jimenez owns 75,796 shares of GE HealthCare Technologies stock worth more than $6,435,080 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Jimenez may own. Additionally, Mr. Jimenez receives a salary of $2,060,000.00 as Insider at GE HealthCare Technologies. Learn More about Frank R. Jimenez's net worth.

How old is Frank R. Jimenez?

Mr. Jimenez is currently 59 years old. There are 5 older executives and no younger executives at GE HealthCare Technologies. Learn More on Frank R. Jimenez's age.

What is Frank R. Jimenez's salary?

As the Insider of GE HealthCare Technologies Inc., Mr. Jimenez earns $2,060,000.00 per year. There are 2 executives that earn more than Mr. Jimenez. The highest earning executive at GE HealthCare Technologies is Dr. Taha Kass-Hout M.D., M.S., Chief Science & Technology Officer, who commands a salary of $4,610,000.00 per year. Learn More on Frank R. Jimenez's salary.

How do I contact Frank R. Jimenez?

The corporate mailing address for Mr. Jimenez and other GE HealthCare Technologies executives is , , . GE HealthCare Technologies can also be reached via phone at 617-443-3400 and via email at [email protected]. Learn More on Frank R. Jimenez's contact information.

Has Frank R. Jimenez been buying or selling shares of GE HealthCare Technologies?

Frank R. Jimenez has not been actively trading shares of GE HealthCare Technologies during the last ninety days. Most recently, on Wednesday, May 1st, Frank R. Jimenez bought 1,315 shares of GE HealthCare Technologies stock. The stock was acquired at an average cost of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now directly owns 75,796 shares of the company's stock, valued at $5,799,909.92. Learn More on Frank R. Jimenez's trading history.

Who are GE HealthCare Technologies' active insiders?

GE HealthCare Technologies' insider roster includes H. Culp, Jr. (Director), Frank Jimenez (Insider), and Thomas Westrick (President & CEO). Learn More on GE HealthCare Technologies' active insiders.

Are insiders buying or selling shares of GE HealthCare Technologies?

In the last year, GE HealthCare Technologies insiders bought shares 1 times. They purchased a total of 1,315 shares worth more than $100,623.80. In the last year, insiders at the sold shares 5 times. They sold a total of 96,809 shares worth more than $7,900,621.05. The most recent insider tranaction occured on November, 6th when CEO Roland Rott sold 3,577 shares worth more than $309,338.96. Insiders at GE HealthCare Technologies own 0.3% of the company. Learn More about insider trades at GE HealthCare Technologies.

Information on this page was last updated on 11/6/2024.

Frank R. Jimenez Insider Trading History at GE HealthCare Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/1/2024Buy1,315$76.52$100,623.8075,796View SEC Filing Icon  
See Full Table

Frank R. Jimenez Buying and Selling Activity at GE HealthCare Technologies

This chart shows Frank R Jimenez's buying and selling at GE HealthCare Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GE HealthCare Technologies Company Overview

GE HealthCare Technologies logo
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $84.90
Low: $82.41
High: $85.29

50 Day Range

MA: $88.54
Low: $81.76
High: $93.85

2 Week Range

Now: $84.90
Low: $66.39
High: $94.55

Volume

6,101,936 shs

Average Volume

3,413,773 shs

Market Capitalization

$38.79 billion

P/E Ratio

23.32

Dividend Yield

0.15%

Beta

1.24